Stockscreener 앱 받기
0.9682
3.18%
-0.0318
시간 외 거래:
.97
0.0018
+0.19%
전일 마감가:
$1.00
열려 있는:
$1.07
하루 거래량:
622.13K
Relative Volume:
3.59
시가총액:
$86.85M
수익:
-
순이익/손실:
$-30.15M
주가수익비율:
-1.064
EPS:
-0.91
순현금흐름:
$-31.63M
1주 성능:
+15.95%
1개월 성능:
+10.84%
6개월 성능:
+18.19%
1년 성능:
-56.58%
1일 변동 폭
$0.9628
$1.07
1주일 범위
$0.8101
$1.07
52주 변동 폭
$0.49
$2.5899
Context Therapeutics Inc Stock (CNTX) Company Profile
명칭
Context Therapeutics Inc
전화
267-225-7416
주소
2001 MARKET STREET, PHILADELPHIA
CNTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNTX
Context Therapeutics Inc
|
0.9682 | 89.70M | 0 | -30.15M | -31.63M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Context Therapeutics Inc Stock (CNTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-18 | 개시 | Guggenheim | Buy |
| 2025-04-21 | 개시 | William Blair | Outperform |
| 2025-01-08 | 개시 | JMP Securities | Mkt Outperform |
| 2024-11-25 | 개시 | D. Boral Capital | Buy |
| 2024-05-16 | 개시 | Piper Sandler | Overweight |
Context Therapeutics Inc 주식(CNTX)의 최신 뉴스
Market Recap: Is KULR Technology Group Inc. stock forming a cup and handle2025 Big Picture & Short-Term Trading Opportunity Alerts - khodrobank.com
Published on: 2025-09-20 01:34:13 - newser.com
Context Therapeutics Inc. stock trend outlook and recovery pathWeekly Investment Report & Free Risk Controlled Daily Trade Plans - newser.com
Can a trend reversal in Context Therapeutics Inc. lead to recoveryPortfolio Value Report & Expert Approved Momentum Ideas - newser.com
Is Context Therapeutics Inc. still worth holding after the dipGap Down & Weekly Watchlist for Hot Stocks - newser.com
Will Context Therapeutics Inc. stock go up soon2025 Market Outlook & Daily Technical Stock Forecast Reports - newser.com
Developing predictive dashboards with Context Therapeutics Inc. data2025 Support & Resistance & Short-Term High Return Ideas - newser.com
Context Therapeutics (NASDAQ:CNTX) Coverage Initiated at Guggenheim - MarketBeat
Context Therapeutics Inc. (NASDAQ:CNTX) Short Interest Down 56.9% in August - MarketBeat
Context Therapeutics (NASDAQ:CNTX) Now Covered by Analysts at Guggenheim - Defense World
Guggenheim Initiates Coverage of Context Therapeutics (CNTX) with Buy Recommendation - Nasdaq
Leading vs lagging indicators on Context Therapeutics Inc. performanceMarket Sentiment Review & Real-Time Stock Price Movement Reports - newser.com
Analyzing Context Therapeutics Inc. with risk reward ratio chartsJuly 2025 Decliners & Momentum Based Trading Signals - newser.com
Real time alert setup for Context Therapeutics Inc. performanceGold Moves & Weekly Chart Analysis and Guides - newser.com
Analyzing Context Therapeutics Inc. with multi timeframe chartsJuly 2025 PreEarnings & Consistent Profit Trading Strategies - newser.com
How institutional ownership impacts Context Therapeutics Inc. stockOil Prices & Precise Buy Zone Identification - newser.com
AI Stocks: What makes Context Therapeutics Inc stock attractive todayMarket Trend Summary & Weekly Return Optimization Alerts - khodrobank.com
Investor Mood: What’s the RSI of Context Therapeutics Inc. stock2025 Earnings Surprises & Risk Adjusted Buy and Sell Alerts - khodrobank.com
how institutional ownership impacts context therapeutics inc. stockWeekly Profit Recap & Verified Momentum Watchlists - newser.com
Aug Outlook: Can Context Therapeutics Inc. be the next market leader2025 Valuation Update & Long-Term Safe Investment Ideas - khodrobank.com
Will earnings trigger a reversal in Context Therapeutics Inc.New Guidance & AI Powered Market Trend Analysis - newser.com
Published on: 2025-09-17 04:58:56 - newser.com
Real time breakdown of Context Therapeutics Inc. stock performanceJuly 2025 Setups & Free Accurate Trade Setup Notifications - newser.com
How to recover losses in Context Therapeutics Inc. stockWeekly Profit Analysis & Weekly High Return Forecasts - newser.com
Published on: 2025-09-17 02:02:32 - newser.com
Aug Final Week: Will Context Therapeutics Inc stock go up in YEARQuarterly Market Summary & AI Driven Stock Reports - khodrobank.com
What data driven models say about Context Therapeutics Inc.’s future2025 Risk Factors & Expert Curated Trade Setups - newser.com
Can Context Therapeutics Inc. rally from current levelsInflation Watch & Technical Pattern Alert System - newser.com
Risk Off: Is Context Therapeutics Inc. a strong candidate for buy and holdJuly 2025 Chart Watch & Reliable Breakout Forecasts - خودرو بانک
Fed Watch: Can Context Therapeutics Inc. ride the EV waveDividend Hike & Low Drawdown Investment Ideas - khodrobank.com
Context Therapeutics Begins Phase 1 Trial of CT-95 Targeting Mesothelin-Expressing Cancers - MSN
Published on: 2025-09-16 09:03:19 - newser.com
Published on: 2025-09-16 16:44:30 - khodrobank.com
Risk Off: How cyclical is Context Therapeutics Incs revenue stream2025 Growth vs Value & Fast Entry Momentum Alerts - khodrobank.com
Will Context Therapeutics Inc. bounce back from current support2025 Risk Factors & Accurate Intraday Trade Tips - newser.com
Retail Surge: Will Context Therapeutics Inc benefit from government policyWeekly Trade Summary & Breakout Confirmation Trade Signals - خودرو بانک
Value Recap: Can Context Therapeutics Inc stock double in the next yearWeekly Market Report & Long-Term Safe Investment Ideas - khodrobank.com
When is the best time to exit Context Therapeutics Inc.2025 Technical Overview & Fast Momentum Entry Tips - newser.com
Quarterly Recap: Is Nabors Energy Transition Corp II vulnerable to short sellersJuly 2025 Update & Safe Investment Capital Preservation Plans - خودرو بانک
Value Recap: How is 3D Systems Corporation managing supply chain issuesJuly 2025 Opening Moves & Weekly Chart Analysis and Trade Guides - خودرو بانک
Earnings Miss: What is the PEG ratio of Context Therapeutics IncJuly 2025 Pullbacks & Intraday High Probability Alerts - khodrobank.com
Trend Review: Is Context Therapeutics Inc. stock suitable for long term investingQuarterly Risk Review & High Conviction Investment Ideas - خودرو بانک
Insider Buy: How does Context Therapeutics Inc compare to its peersWeekly Trade Summary & Growth Focused Stock Pick Reports - خودرو بانک
Analysts Set Context Therapeutics Inc. (NASDAQ:CNTX) Price Target at $5.25 - MarketBeat
Applying Wyckoff theory to Context Therapeutics Inc. stockPortfolio Update Summary & Real-Time Volume Analysis - newser.com
Is now a turning point for Context Therapeutics Inc.Market Trend Report & Fast Momentum Stock Entry Tips - newser.com
Context Therapeutics Inc (CNTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Context Therapeutics Inc 주식 (CNTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Levit Alex C. | Chief Legal Officer, Corp. Sec |
Jun 06 '25 |
Buy |
0.58 |
20,000 |
11,520 |
29,000 |
| Minai-Azary Jennifer Lynn | Chief Financial Officer |
Jun 06 '25 |
Buy |
0.64 |
40,010 |
25,486 |
80,010 |
1.43%
0.09%
자본화:
|
볼륨(24시간):